Dana Pizzuti is Chief Med and Dev Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 72,233 shares of CRNX, which is worth approximately $2.18 Million. The most recent transaction as insider was on Mar 01, 2023, when has been sold 4,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 72.2K
0% 3M change
159.96% 12M change
Total Value Held $2.18 Million

Dana Pizzuti Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2023
BUY
Grant, award, or other acquisition
-
4,500 Added 20.93%
17,000 Common Stock
Oct 10 2022
BUY
Grant, award, or other acquisition
-
12,500 Added 50.0%
12,500 Common Stock
DP

Dana Pizzuti

Chief Med and Dev Officer
San Diego, CA

Track Institutional and Insider Activities on CRNX

Follow Crinetics Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRNX shares.

Notify only if

Insider Trading

Get notified when an Crinetics Pharmaceuticals, Inc. insider buys or sells CRNX shares.

Notify only if

News

Receive news related to Crinetics Pharmaceuticals, Inc.

Track Activities on CRNX